| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |